NCT00355680

Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy

Comparative Study of Indigenous Green Laser With Already Available Green Laser in Proliferative Diabetic Retinopathy

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Aurolab · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To Demonstrate that indigenous green laser produces similar treatment effect on the retina when compared with already available green laser.

Detailed description

Proliferative Diabetic Retinopathy is ocular pathology in poor glycaemic controlled Diabetic patient Characterized by micro-vascular pathology with capillary closure in the retina leading to hypoxia of tissue there by formation of immature vessels to provide better oxygenation of retinal tissue. In this randomized double blinded study a convenient sample size of 24 eyes assigned to compare indigenously developed green laser with already available green laser.

Conditions

• Diabetic Retinopathy

Interventions

Type	Name	Description
DEVICE	Green Laser (Aurolas, Aurolab)	Green laser developed by Aurolab
DEVICE	Green Laser (Iridex)	Already available green laser

Timeline

• Start date: 2005-12-01
• Primary completion: 2006-07-01
• Completion: 2006-07-01
• First posted: 2006-07-24
• Last updated: 2009-02-11

Locations

1 site across 1 country: India